APA
Gonzalez-Angulo A. M., Akcakanat A., Liu S., Green M. C., Murray J. L., Chen H., Palla S. L., Koenig K. B., Brewster A. M., Valero V., Ibrahim N. K., Moulder-Thompson S., Litton J. K., Tarco E., Moore J., Flores P., Crawford D., Dryden M. J., Symmans W. F., Sahin A., Giordano S. H., Pusztai L., Do K., Mills G. B., Hortobagyi G. N. & Meric-Bernstam F. (20150121). Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Gonzalez-Angulo A M, Akcakanat A, Liu S, Green M C, Murray J L, Chen H, Palla S L, Koenig K B, Brewster A M, Valero V, Ibrahim N K, Moulder-Thompson S, Litton J K, Tarco E, Moore J, Flores P, Crawford D, Dryden M J, Symmans W F, Sahin A, Giordano S H, Pusztai L, Do K-A, Mills G B, Hortobagyi G N and Meric-Bernstam F. 20150121. Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Gonzalez-Angulo A. M., Akcakanat A., Liu S., Green M. C., Murray J. L., Chen H., Palla S. L., Koenig K. B., Brewster A. M., Valero V., Ibrahim N. K., Moulder-Thompson S., Litton J. K., Tarco E., Moore J., Flores P., Crawford D., Dryden M. J., Symmans W. F., Sahin A., Giordano S. H., Pusztai L., Do K., Mills G. B., Hortobagyi G. N. and Meric-Bernstam F. (20150121). Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Gonzalez-Angulo A M, Akcakanat A, Liu S, Green M C, Murray J L, Chen H, Palla S L, Koenig K B, Brewster A M, Valero V, Ibrahim N K, Moulder-Thompson S, Litton J K, Tarco E, Moore J, Flores P, Crawford D, Dryden M J, Symmans W F, Sahin A, Giordano S H, Pusztai L, Do K-A, Mills G B, Hortobagyi G N and Meric-Bernstam F. Open-label randomized clinical trial of standard neoadjuvant chemotherapy with paclitaxel followed by FEC versus the combination of paclitaxel and everolimus followed by FEC in women with triple receptor-negative breast cancer†. : Annals of oncology : official journal of the European Society for Medical Oncology. 20150121.